XT
CNTB

XTX Topco’s Connect Biopharma Holdings CNTB Stock Holding History

XTX Topco’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Sell
28,659
-12,469
-30% -$30.2K ﹤0.01% 3632
2026
Q1 		$108K Buy
+41,128
New +$107K ﹤0.01% 3079
2025
Q4 		– Sell
-23,724
Closed -$35.1K – 3377
2025
Q3 		$35.1K Sell
23,724
-5,138
-18% -$9.1K ﹤0.01% 2234
2025
Q2 		$28.9K Buy
+28,862
New +$23K ﹤0.01% 2116
2024
Q1 		– Sell
-15,506
Closed -$18.3K – 1902
2023
Q4 		$18.3K Buy
+15,506
New +$18.4K ﹤0.01% 1368

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

XTX Topco's CNTB Position: Q2 2026 in Review

XTX Topco reduced its Connect Biopharma Holdings (CNTB) stake by 30% in Q2 2026, selling an estimated $30.2K and leaving 28,659 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3632.

XTX Topco first reported a position in CNTB in Q4 2023 and has held it in 5 quarters since. The position peaked at $108K in Q1 2026. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • XTX Topco held 28,659 shares of Connect Biopharma Holdings worth $68.2K as of Q2 2026.
  • XTX Topco sold 12,469 Connect Biopharma Holdings shares in Q2 2026, an estimated $30.2K.
  • Connect Biopharma Holdings made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3632 holding.
  • XTX Topco first reported a position in Connect Biopharma Holdings in Q4 2023 and has held it in 5 quarters since.
  • XTX Topco's Connect Biopharma Holdings position peaked at $108K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.